Advertisement
Home Tags Vaccines

Tag: Vaccines

Highlighting what might happen if children aren't vaccinated can change the thinking of some people who oppose vaccines

Focus on Consequences May Help Sway Anti-Vaccine Beliefs

0
When parents learn about the harms of measles, mumps, and rubella, many change their stance
For 11- to 15-year olds

Concomitant Administration of 9vHPV With MCV4/Tdap Feasible

0
Noninferior to intermittent administration of vaccines for 11- to 15-year olds
An experimental Ebola vaccine appears highly effective

WHO: ‘Ring’ Vaccination for Ebola Very Promising

0
Initial trials in Guinea show 100 percent effectiveness; larger trials are planned
Four out of 10 girls and six out of 10 boys

CDC: Too Few U.S. Adolescents Getting HPV Vaccination

0
4 out of 10 girls, 6 out of 10 boys haven't started series
Among patients with diabetes

Extensive Nonadherence to Vaccine Guidelines in Diabetes

0
Ubiquitous nonadherence to 2011 Advisory Committee's hepatitis B recommendation
An individual's genetic makeup may determine whether an HIV vaccine will work

Genes May Be Key to a Better HIV Vaccine

0
Findings challenge one-shot-fits-all approach, could guide development of future vaccines
Almost a decade after the human papillomavirus vaccine was first recommended for girls

Few U.S. States Mandate Human Papillomavirus Vaccine

0
Immunization protects against sexually transmitted disease, certain cancers, health experts say
American parents' views about childhood vaccines became more favorable over the past year

Poll Finds More Parents See Benefits, Safety of Vaccines

0
Reports on outbreaks of measles, pertussis in past year may have shifted opinions, pediatrician says
The U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has voted to issue a category B recommendation for use of two serogroup B meningococcal vaccines in patients aged 16 to 23 years for short-term disease prevention

ACIP Recommends MenB Vaccine for 16- to 23-Year-Olds

0
Category B recommendation for short-term protection against meningitis for all aged 16 to 23
The 13-valent pneumococcal vaccine (PCV-13) is expected to be cost saving compared with PCV7

PCV13 Predicted to Be Cost Saving Versus PCV7

0
Although 13-valent pneumococcal vaccine is more costly than PCV7, net cost savings expected